SCCR 22: Opening statement of the Asian Group
Asian Group’s Statement
22nd session of the Standing Committee on Copyright and Related Rights
(15-24 June 2011)1. I have the honour to take the floor on behalf of the Asian Group.
Opening statement of Uruguay at WIPO’s 22nd Standing Committee on Copyright and Related Rights
Comité Permanente de Derechos de Autor y Conexos – SCCR 22 – OMPI – Ginebra
Intervención de la Delegación de Uruguay. Ginebra, 15 de junio de 2011.Gracias Señor Presidente,
Señor Presidente, reciba de nuestra delegación nuestras mas sinceras felicitaciones por su designación como Presidente del Comité Permanente de Derechos de Autor y Conexos SCCR y cuente con nuestro apoyo para hacer una exitosa gestión al frente de este importante comité.
Señor Presidente:
White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs)
Draft of the Political Declaration on HIV and AIDS disappoints public health NGOs
FDA New drug approvals for 2011, through June 6
This is a report from the FDA on 2011 new molecular entities (NMEs) approvals, through June 6, 2011. The total number of FDA approvals during that same period was 150. So far, 16 NMEs have been approved in five months, a sharp increase in approvals over the same period 2010.
6 NMEs NDAs were considered priorities
8 NDAs that were considered standard approvals
2 BLA (biologic products) that were not classified.
- NMEs were 10.7 percent of all approvals.
- The NME priority NDAs were 4 percent of FDA approvals.
Senator Sanders introduces two medical innovation prize bills in U.S. Senate to de-link R&D costs from drug prices
On Thursday, May 26, 2011, Senator Bernie Sanders (I-VT) introduced two bills in the United States Senate that would de-link R&D costs from drug prices. The bill names and numbers are as follows:
Letter to the 129th WHO Executive Board on conflicts of interest, WHO reform and the future of financing
24 May 2011
NGO letter on Conflicts of Interest, Future Financing, Reform and governance of the WHO.
Dear Members of the Executive Board,
SCP 16: Summary by the Chair
WIPO
World Intellectual Property OrganizationSCP/16/8 PROV.
ORIGINAL: ENGLISH
DATE: MAY 20, 2011Standing Committee on the Law of Patents
Sixteenth Session
Geneva, May 16 to 20, 2011SUMMARY BY THE CHAIR
Agenda Item 1: Opening of the session
1. The sixteenth of the Standing Committee on the Law of Patents (SCP) was opened by Mr. James Pooley, Deputy Director General, who welcomed the participants. Mr. Philippe Baechtold (WIPO) acted as Secretary.
Continue ReadingBRICS Health Ministers’ preparatory meeting – May 17th 2011
BRICS Health Ministers’ preparatory meeting – May 17th 2011
Press releaseConsistent with the mandate of the Sanya Declaration of the BRICS Leaders Meeting (14 April 2011), the Ministers of Health of the five BRICS’ countries met on the sidelines of the 64thWorld Health Assembly, on 17 May 2011, to discuss issues of common interest as well as prepare the BRICS Health Ministerial Meeting to be held in Beijing, China, on 11 July 2011. Representatives of WHO and UNAIDS also attended the meeting.
SCP16: KEI intervention on Patents and Health
16th session of the WIPO Standing Committee of the Law of Patents (SCP)
Thursady, 19 May 2011KEI Statement on Patents and Health
KEI is impressed by and fully supportive of the joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health, which has been published as SCP/16/7. We agree with the comments of the Chair that the proposal is both comprehensive and well thought out.